Mitochondrial therapy for Parkinson’s disease: Neuroprotective pharmaconutrition may be disease-modifying

Progressive destruction of neurons that produce dopamine in the basal ganglia of the brain, particularly the substantia nigra, is a hallmark of Parkinson’s disease. The syndrome of the Parkinsonian phenotype is caused by many etiologies, involving multiple contributing mechanisms. Characteristic fin...

Descripción completa

Detalles Bibliográficos
Autor principal: Kones, Richard
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove Medical Press 2010
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3262379/
https://www.ncbi.nlm.nih.gov/pubmed/22291504
http://dx.doi.org/10.2147/CPAA.S12082

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3262379/
https://www.ncbi.nlm.nih.gov/pubmed/22291504
http://dx.doi.org/10.2147/CPAA.S12082

Ejemplares similares